Placental Disorders are conditions that affect the development, structure, position, attachment, blood flow, function or separation of the placenta during pregnancy. The placenta is a temporary organ that develops from fetal and maternal tissues and performs several essential functions: it facilitates exchange of oxygen, carbon dioxide, nutrients and waste products; produces hormones that maintain pregnancy and prepare the body for birth; contributes to immune and endocrine regulation; and forms a selective interface between maternal and fetal circulations.
Disorders can therefore affect either maternal wellbeing, fetal wellbeing, or both. They include abnormalities of placental implantation and location, impaired placental function, premature separation, abnormal adherence to the uterine wall, infarction, thrombosis, inflammation and other structural or vascular abnormalities. The term is broad and does not denote one specific diagnosis. Understanding the placenta is particularly important because many obstetric complications, including fetal growth restriction, Pre-eclampsia, bleeding and stillbirth, can arise through placental dysfunction even when the placenta appears superficially normal during pregnancy.
Placental development begins soon after implantation, when trophoblast cells interact with the uterine lining and establish the early exchange interface. Extravillous trophoblasts invade maternal tissue and remodel spiral arteries, converting them from relatively narrow, muscular vessels into high-capacitance, low-resistance channels. Chorionic villi contain fetal capillaries and provide the microscopic surface across which substances are exchanged. The placenta also produces hormones such as human chorionic gonadotrophin, progesterone, oestrogens and human placental lactogen, with endocrine functions changing throughout gestation.
Abnormal placentation can occur when implantation, trophoblast invasion or vascular remodelling is disturbed. The consequences depend on which component is affected. Poor spiral-artery remodelling can contribute to placental insufficiency and Pre-eclampsia, while excessive trophoblast invasion can produce placenta accreta spectrum. Abnormal implantation near the cervix can cause Placenta Praevia, while premature separation produces placental abruption. Thus, different Placental Disorders can arise from different stages or mechanisms of placental development.
Placental insufficiency refers broadly to inadequate placental function relative to fetal requirements. It may lead to reduced nutrient and oxygen delivery, impaired fetal growth and abnormal Doppler blood-flow measurements. Fetal growth restriction is not synonymous with being constitutionally small: some small fetuses are healthy, while growth restriction implies pathological limitation of growth potential. Placental insufficiency can result from maternal vascular disease, hypertensive disorders, thrombosis, placental infarction, abnormal implantation or other mechanisms.
Affected pregnancies may require serial ultrasound measurements and assessment of umbilical-artery, middle-cerebral-artery or ductus-venosus blood flow in selected circumstances. Placental function can deteriorate gradually or, in some cases, abruptly. Because the placenta is the organ connecting maternal physiology to fetal oxygenation, disorders affecting maternal circulation can have fetal consequences even when the mother feels well. This relationship explains why placental assessment is a central component of high-risk antenatal care.
Placental separation disorders represent another major group. Placental abruption occurs when the placenta separates partially or completely from the uterine wall before the baby is delivered. It can cause painful vaginal bleeding, abdominal or back pain, uterine tenderness and fetal compromise, although visible bleeding may be absent if blood remains concealed behind the placenta. Risk factors include hypertension, previous abruption, smoking, trauma and certain obstetric circumstances.
The placenta can also become abnormally adherent or invasive, collectively described within the placenta accreta spectrum. In these disorders, placental tissue attaches too deeply into the uterine wall because the normal boundary between placenta and myometrium is deficient. Placenta accreta, increta and percreta represent increasing degrees of invasion. The condition can cause severe haemorrhage when the placenta fails to separate normally after birth. Antenatal recognition allows delivery planning in a specialist setting with appropriate blood products, surgical expertise and multidisciplinary support.
Placental Disorders are often evaluated through ultrasound, Doppler imaging, clinical assessment and examination of the placenta after delivery. Ultrasound can identify placental location, certain structural abnormalities and features suggestive of invasive placentation. Doppler studies evaluate blood flow and are especially useful when placental insufficiency or fetal growth restriction is suspected. Magnetic resonance imaging may occasionally provide additional information for selected cases of suspected invasive placentation, although it is not required for every patient.
After delivery, pathological examination can reveal infarction, inflammation, thrombosis, abruption, abnormal maturation and other microscopic changes. Interpretation requires expertise because placental lesions can be incidental and their significance depends on extent, distribution and clinical context. A placental finding should therefore not automatically be labelled as the cause of an adverse pregnancy outcome without considering maternal, fetal and obstetric evidence.
Management varies dramatically according to the specific Placental Disorders involved. A low-lying placenta that remains safely away from the cervix may require little intervention, while Placenta Praevia can necessitate planned caesarean birth. Placental insufficiency may require increased surveillance and, if fetal or maternal risk becomes too high, planned early delivery. Placental abruption can require immediate maternal stabilisation and urgent delivery when severe.
Placenta accreta spectrum requires carefully planned delivery because attempts to forcibly remove an invasive placenta can cause catastrophic haemorrhage. Corticosteroids may be used when preterm birth is anticipated, and magnesium sulfate may be considered for neuroprotection at very early gestational ages according to local guidance. Blood-bank preparation is particularly important in conditions associated with haemorrhage. The treatment principle is therefore not to treat the placenta as a single disease entity but to address the specific anatomical or physiological abnormality and its consequences.
Placental Disorders have major implications for both maternal and fetal outcomes because the placenta sits at the intersection of maternal circulation, uterine anatomy and fetal physiology. They contribute to important causes of premature birth, fetal growth restriction, stillbirth, antepartum haemorrhage and maternal haemorrhage. Some disorders can be predicted from maternal history or identified during routine ultrasound, whereas others become apparent only through symptoms or complications.
Risk factors can overlap: hypertension can contribute to placental insufficiency and abruption, while previous uterine surgery can increase the risk of abnormal invasive placentation and low placental implantation. The relationship between these disorders is therefore networked rather than isolated. Research increasingly treats placental biology as a central determinant of pregnancy health, using molecular, genetic, imaging and pathological approaches to understand why apparently similar pregnancies can have very different outcomes.
The placenta also has an important role after pregnancy because examination of placental tissue can provide information about why a pregnancy was complicated by growth restriction, Pre-eclampsia, infection, abruption or stillbirth. Placental pathology can sometimes identify evidence of maternal vascular malperfusion, fetal vascular malperfusion, inflammatory lesions or abnormal implantation. Such information can influence counselling and surveillance in future pregnancies, although it cannot always predict recurrence.
The placenta is therefore both an active biological organ during pregnancy and a source of diagnostic information after delivery. Its disorders illustrate the importance of viewing pregnancy as an integrated maternal-fetal system: abnormal placental development can manifest as maternal hypertension, fetal growth problems, bleeding, premature birth or fetal death. The broad term Placental Disorders consequently encompasses a diverse set of conditions linked by their effect on an organ essential for maintaining pregnancy and supporting fetal development.
